Pastorello E A, Incorvaia C, Ortolani C, Bonini S, Canonica G W, Romagnani S, Tursi A, Zanussi C
First Department of Internal Medicine, University of Milan, Italy.
J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):580-7. doi: 10.1016/s0091-6749(95)70255-5.
The detection of specific IgE antibodies to environmental allergens does not always coincide with a diagnosis of clinically evident allergic disease, because some patients with positive skin and/or in vitro test results have no symptoms related to the allergen or allergens that induced the antibodies.
In a multicenter study the optimal cutoff values for specific IgE antibody levels and skin test results that could discriminate between patients with symptomatic and those with asymptomatic allergy were determined.
IgE antibodies specific for a panel of common aeroallergens were assayed with the Pharmacia CAP System (Pharmacia, Uppsala, Sweden) in two groups of patients, a group of 267 patients with symptomatic allergy and a group of 232 with asymptomatic allergy--both with positive skin prick test results--and in a group of 243 healthy, nonallergic control subjects. The cutoff values were established by receiver operating characteristic analysis.
A significantly higher mean specific IgE antibody value was found in patients with symptomatic allergy compared with patients with asymptomatic allergy (p < 0.001) and in patients with symptomatic allergy compared with healthy control subjects (p < 0.001). The optimal CAP System cutoff value between patients with symptomatic and those with asymptomatic allergy was 11.7 kU/L, and when seasonal allergens were compared with perennial allergens, the cutoffs were 10.7 kU/L and 8.4 kU/L, respectively. The optimal cutoff value for the skin prick test was a wheel area of 32 mm2 for seasonal allergens and 31 mm2 for perennial allergens. The skin test had a lower diagnostic value (sum of sensitivity and specificity) than the CAP System.
Cutoff values for specific serum IgE antibody levels are likely to be useful in clinical practice to distinguish symptomatic from asymptomatic allergy in patients with positive skin test results.
针对环境过敏原的特异性IgE抗体检测结果并不总是与临床明显的过敏性疾病诊断结果相符,因为一些皮肤和/或体外检测结果呈阳性的患者并无与诱导产生抗体的一种或多种过敏原相关的症状。
在一项多中心研究中,确定能够区分有症状过敏患者和无症状过敏患者的特异性IgE抗体水平及皮肤试验结果的最佳临界值。
使用Pharmacia CAP系统(瑞典乌普萨拉的Pharmacia公司)对两组患者检测了针对一组常见气传过敏原的IgE抗体,一组为267名有症状过敏患者,另一组为232名无症状过敏患者(两组患者皮肤点刺试验结果均为阳性),并检测了243名健康非过敏对照者。通过受试者操作特征分析确定临界值。
与无症状过敏患者相比,有症状过敏患者的平均特异性IgE抗体值显著更高(p<0.001);与健康对照者相比,有症状过敏患者的平均特异性IgE抗体值也显著更高(p<0.001)。有症状过敏患者与无症状过敏患者之间的最佳CAP系统临界值为11.7 kU/L,将季节性过敏原与常年性过敏原进行比较时,临界值分别为10.7 kU/L和8.4 kU/L。皮肤点刺试验的最佳临界值为,季节性过敏原的风团面积为32 mm²,常年性过敏原的风团面积为31 mm²。皮肤试验的诊断价值(敏感性与特异性之和)低于CAP系统。
对于皮肤试验结果呈阳性的患者,特异性血清IgE抗体水平的临界值可能有助于在临床实践中区分有症状过敏与无症状过敏。